Literature DB >> 20338557

Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes.

Denusa Wiltgen1, Poli Mara Spritzer.   

Abstract

The aim of this study was to compare clinical, hormonal, and metabolic variables in women with classic polycystic ovary syndrome (PCOS), in ovulatory women presenting hirsutism, normal androgen levels, and polycystic ovaries (H+PCO), and in a group with isolated hirsutism (IH) presenting with normal ovaries and androgen levels. Waist circumference, triglycerides, and homeostasis model assessment values were significantly higher in classic PCOS even after adjustment for body mass index, and metabolic syndrome was three times more frequent in classic PCOS than in H+PCO or IH (31.3% vs. 11.9% vs. 9%), but no differences were observed regarding metabolic profile and cardiovascular risk factors between the H+PCO and IH groups, which presented with significantly more metabolic syndrome than normal controls when only overweight and obese women were considered.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20338557     DOI: 10.1016/j.fertnstert.2010.02.015

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  20 in total

1.  Habitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional study.

Authors:  F M Mario; S K Graff; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2016-10-22       Impact factor: 4.256

Review 2.  Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens.

Authors:  Licy L Yanes Cardozo; Damian G Romero; Jane F Reckelhoff
Journal:  Physiology (Bethesda)       Date:  2017-09

3.  Bak Foong pills combined with metformin in the treatment of a polycystic ovarian syndrome rat model.

Authors:  Wenhui Liu; Wenpei Liu; Yuling Fu; Yan Wang; Yuanzhen Zhang
Journal:  Oncol Lett       Date:  2015-07-08       Impact factor: 2.967

4.  Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome.

Authors:  Ebru Çelik; Ilgın Türkçüoğlu; Barış Ata; Abdullah Karaer; Pınar Kırıcı; Sevil Eraslan; Çağatay Taşkapan; Bülent Berker
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01

5.  Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes.

Authors:  Berna Dilbaz; Enis Ozkaya; Mehmet Cinar; Evrim Cakir; Serdar Dilbaz
Journal:  Endocrine       Date:  2011-03-10       Impact factor: 3.633

6.  Haplotype TGTG from SNP 45T/G and 276G/T of the adiponectin gene contributes to risk of polycystic ovary syndrome.

Authors:  S Radavelli-Bagatini; I O de Oliveira; R B Ramos; B R Santos; M S Wagner; S B Lecke; D P Gigante; B L Horta; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

7.  Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008.

Authors:  Ekwutosi M Okoroh; W Craig Hooper; Hani K Atrash; Hussain R Yusuf; Sheree L Boulet
Journal:  Am J Obstet Gynecol       Date:  2012-08-10       Impact factor: 8.661

8.  Single nucleotide polymorphisms in binding site of miRNA-135a and targeted gene IRS2 are correlated with multiple clinical features of PCOS: A study in Chinese women.

Authors:  Heng Gu; Longyu Li; Bingyi Zhou; Mingzhen Li; Wenyao Zhong; Xiangcai Wei; Xingmin Zhong
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

9.  Pathway Analysis Based on a Genome-Wide Association Study of Polycystic Ovary Syndrome.

Authors:  Unjin Shim; Han-Na Kim; Hyejin Lee; Jee-Young Oh; Yeon-Ah Sung; Hyung-Lae Kim
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

Review 10.  Complications and challenges associated with polycystic ovary syndrome: current perspectives.

Authors:  Stefano Palomba; Susanna Santagni; Angela Falbo; Giovanni Battista La Sala
Journal:  Int J Womens Health       Date:  2015-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.